GMTX News and Press, Gemini Therapeutics Inc. From 08/12/21

- Initial data from ongoing Phase 2a study in geographic atrophy demonstrated ability of GEM103 to durably regulate complement and showed a differentiated safety profile with no increased risk of CNV - Completed enrollment in Phase 2a study of GEM103 in wet AMD with six-month ...

Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that Jason Meyeburg, Chief Executive Officer of Gemini Therapeutics, is scheduled to par...

Shares of Gemini Therapeutics Inc. (NASDAQ:GMTX) traded at a new 52-week low today of $4.60. This new low was reached on approximately average trading volume as 660,000 shares traded hands, while the average 30-day volume is approximately 760,000 shares. Gemini Therapeutics Inc. (NASDAQ:...

Gemini Therapeutics Inc. (NASDAQ:GMTX) traded at a new 52-week low today of $4.90. Approximately 660,000 shares have changed hands today, as compared to an average 30-day volume of 749,000 shares. Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel the...

Gemini Therapeutics Inc. (NASDAQ:GMTX) traded today at a new 52-week low of $4.85. This new low was reached on approximately average trading volume as 660,000 shares traded hands, while the average 30-day volume is approximately 749,000 shares. Gemini Therapeutics Inc. (NASDAQ:GMTX) is c...

Gemini Therapeutics Inc. (NASDAQ:GMTX) traded today at a new 52-week low of $5.94. So far today approximately 660,000 shares have been exchanged, as compared to an average 30-day volume of 197,000 shares. Gemini Therapeutics Inc. (NASDAQ:GMTX) is currently priced 89.7% above its average ...

Gemini Therapeutics Inc. (NASDAQ:GMTX) traded at a new 52-week low today of $6.26. Approximately 660,000 shares have changed hands today, as compared to an average 30-day volume of 197,000 shares. Gemini Therapeutics Inc. (NASDAQ:GMTX) defies analysts with a current price ($6.32) 90.2% a...

Shares of Gemini Therapeutics Inc. (NASDAQ:GMTX) traded today at $6.44, breaking its 52-week low. So far today approximately 660,000 shares have been exchanged, as compared to an average 30-day volume of 197,000 shares. Gemini Therapeutics Inc is a clinical-stage precision medicine compa...

JuSun/iStock via Getty Images During the week ended June 25, 2021, Healthcare sector rose 2.01% and Healthcare Select Sector SPDR ETF (XLV) gained 1.58% compared to weekly gain of 2.82% of S&P 500 ETF. Leading the top gainers pack was Atossa Therapeutics (ATO...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P 500 closed the week at another record high, posting its best weekly performance since February, as investors bet that higher infl...